Illumina’s Bold Move: Acquiring SomaLogic to Revolutionize Proteomics and Multiomics
Illumina’s acquisition of SomaLogic, announced on June 23, 2025, boosts its proteomics and multiomics strategy. Combining SomaLogic’s protein analysis with Illumina’s sequencing expertise, the deal aims to revolutionize biological research and precision medicine, promising deeper insights into diseases and treatments.